City of Owasso v. Purdue Pharma L.P. et al
City of Owasso |
Purdue Pharma L.P., Mallinckrodt LLC, Anda Pharmaceuticals, Inc., Mallinckrodt PLC, Insys Therapeutics, Inc., Physicians Total Care Inc, Watson Laboratories Inc., Allergan PLC, Teva Pharmaceuticals USA, Inc., Keysource Medical, Inc., Janssen Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Actavis LLC, Janssen Phamaceutica, Inc., Joshua Livingston, Quest Pharmaceuticals, Inc., Cephalon Inc., Actavis Pharma, Inc., Perry Fine, Amerisourcebergen Corp., Cardinal Health Inc., Activas PLC, Endo Health Solutions Inc., Johnson & Johnson, Watson Pharmaceuticals, Inc., Anda Inc, Harvard Drug Company, LLC, McKesson Corp., Lynn Webster, GCP Pharma LLC, Watson Pharma, Inc., Officer Jeremy Thomas, Morris & Dickson Co LLC, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma Inc. and Purdue Frederick Company, Inc., The |
1:2019op45718 |
September 6, 2019 |
US District Court for the Northern District of Ohio |
Dan Aaron Polster (MDL 2804) |
P.I.: Other |
Both |
Docket Report
This docket was last retrieved on October 30, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 78 Amended complaint against Actavis LLC, Actavis Pharma, Inc., Activas PLC, Allergan PLC, Amerisourcebergen Corp., Anda Inc, Anda Pharmaceuticals, Inc., Cardinal Health Inc., Cephalon Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Perry Fine, GCP Pharma LLC, Harvard Drug Company, LLC, Insys Therapeutics, Inc., Janssen Phamaceutica, Inc., Janssen Pharmaceuticals Inc., Johnson & Johnson, Keysource Medical, Inc., Joshua Livingston, Mallinckrodt LLC, Mallinckrodt PLC, McKesson Corp., Morris & Dickson Co LLC, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Physicians Total Care Inc, Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P., Quest Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Jeremy Thomas, Watson Laboratories Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc., Lynn Webster, L. & R. Distributors, Inc., doing business as SAJ Distributors, H.D. Smith, LLC, Medisca Inc., Walgreens Boots Alliance, Inc., also known as Walgreen Co. and adding new party defendant(s) L. & R. Distributors, Inc., H.D. Smith, LLC, Medisca Inc. and Walgreens Boots Alliance, Inc., also known as Walgreen Co.. Filed by City of Owasso. (Puckett, Tony) |
Filing 77 CASE TRANSFERRED IN from District of Oklahoma Northern. Case number 4:19-cv-00171. Original file, certified copy of transfer order and docket sheet received. |
***Civil Case Terminated (see document number #76 ) (sac-qc, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 76 ORDER by Sarah S Vance, Chair of the MDL Panel, transferring case (terminates case) (Documents Terminated: #44 MOTION to Remand , #53 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) (jln, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 75 ***Remark: Received Minute Order from MDL re: transferee court to transmit a certified copy of the Panel Transfer Order (jln, Dpty Clk) Modified on 8/1/2019 to correct file date (jln, Dpty Clk). [Transferred from oknd on 9/6/2019.] |
Filing 74 ***Remark: Received Transfer Order re:action under Panel Rule 7.1 to vacate conditional transfer orders (jln, Dpty Clk) Modified on 8/1/2019 to correct file date (jln, Dpty Clk). [Transferred from oknd on 9/6/2019.] |
Filing 73 NOTICE of Change of Address by Kaylee Patricia Davis-Maddy by on behalf of McKesson Corp. (Davis-Maddy, Kaylee) [Transferred from oknd on 9/6/2019.] |
Filing 72 CORPORATE DISCLOSURE STATEMENT by Insys Therapeutic, Inc. (Pierce, Amy) [Transferred from oknd on 9/6/2019.] |
Filing 71 MINUTE ORDER by Court Clerk , directing Insys Therapeutic, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 70 NOTICE of Filing Bankruptcy by Insys Therapeutic, Inc. (Pierce, Amy) [Transferred from oknd on 9/6/2019.] |
Filing 69 ORDER by Judge Gregory K Frizzell ; terminating attorney Tiffany Ikeda ; granting #68 Motion to Withdraw Attorney(s) (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 68 MOTION to Withdraw Attorney(s) Tiffany M. Ikeda (With Notice of Motion to Withdraw) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 67 MINUTE ORDER by Court Clerk , directing Teva Pharmaceutical Industries, Ltd., Activas PLC, Watson Pharmaceuticals, Inc., Watson Pharma, Inc., to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 66 Joint REPLY to Response to Motion (Re: #53 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. ; (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 65 MINUTE ORDER by Judge Gregory K Frizzell granting admission pro hac vice for attorney Brian Ercole ; granting #62 Motion for Admission Pro Hac Vice (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 64 MINUTE ORDER by Judge Gregory K Frizzell granting admission pro hac vice for attorney Steven Reed ; granting #61 Motion for Admission Pro Hac Vice (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 63 MINUTE ORDER by Judge Gregory K Frizzell granting admission pro hac vice for attorney Harvey Bartle ; granting #60 Motion for Admission Pro Hac Vice (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 62 MOTION for Attorney(s) Brian Ercole to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2057433) by Actavis LLC, Actavis Pharma Inc., Activas PLC, Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. (With attachments) (McCampbell, Robert) [Transferred from oknd on 9/6/2019.] |
Filing 61 MOTION for Attorney(s) Steven Reed to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2057432) by Actavis LLC, Actavis Pharma Inc., Activas PLC, Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. [Note: Attorney Robert Garner McCampbell added to party Activas PLC(pty:dft).] (With attachments) (McCampbell, Robert) [Transferred from oknd on 9/6/2019.] |
Filing 60 MOTION for Attorney(s) Harvey Bartle to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2057430) by TEVA Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. [Note: Attorney Robert Garner McCampbell added to party Watson Pharmaceuticals, Inc.(pty:dft).] (With attachments) (McCampbell, Robert) [Transferred from oknd on 9/6/2019.] |
Filing 59 MINUTE ORDER by Judge Gregory K Frizzell granting admission pro hac vice for attorneys Joshua D. Burns, Jonathan S. Tam, and Mark S. Cheffo ; granting #58 Motion for Admission Pro Hac Vice (This entry is the Official Order of the Court. No document is attached.) (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 58 MOTION for Attorney(s) Joshua D. Burns, Jonathan S. Tam, Mark S. Cheffo to be Admitted Pro Hac Vice (paid $150 PHV fee; receipt number 1085-2057287) by Purdue Frederick Company Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. (With attachments) (Lamirand, Jennifer) [Transferred from oknd on 9/6/2019.] |
Filing 57 REPLY to Response to Motion (Re: #44 MOTION to Remand ) by City of Owasso ; (Court, Todd) [Transferred from oknd on 9/6/2019.] |
Filing 56 RESPONSE in Opposition to Motion (Re: #53 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) by City of Owasso ; (With attachments) (Court, Todd) [Transferred from oknd on 9/6/2019.] |
Filing 55 RESPONSE in Opposition to Motion (Re: #44 MOTION to Remand ) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. ; (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 54 RESPONSE in Opposition to Motion (Re: #44 MOTION to Remand ) by McKesson Corp. ; (With attachments) (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 53 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. (With attachments) (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 52 MINUTE ORDER by Court Clerk , directing Mark S Cheffo, Steven A Reed, Brian M Ercole, Harvey Bartle IV, Charles C Lifland, J Matthew Donohue, Joseph L Franco, Joshua D Burns, and Jonathan S Tam to file by 5/23/2019 a Motion for Admission Pro Hac Vice per Local Civil Rule 83.2. Additionally, if you intend to practice in this district in the future and want to become a member of this district, please submit an application for attorney admission. (This entry is the Official Order of the Court. No document is attached.) (eaw, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 51 MINUTE ORDER by Court Clerk , directing Purdue Pharma L.P., Purdue Pharma Inc., The Purdue Frederick Company Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 50 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Pharmaceutical Research Associates, Inc. for Purdue Frederick Company Inc., The) by Purdue Frederick Company Inc., The (Lamirand, Jennifer) [Transferred from oknd on 9/6/2019.] |
Filing 49 CORPORATE DISCLOSURE STATEMENT by Purdue Pharma Inc. (Lamirand, Jennifer) [Transferred from oknd on 9/6/2019.] |
Filing 48 CORPORATE DISCLOSURE STATEMENT (identifying: Other Affiliate Purdue Pharma Inc., Other Affiliate Pharmaceutical Research Associates L.P. for Purdue Pharma L.P.) by Purdue Pharma L.P. (Lamirand, Jennifer) [Transferred from oknd on 9/6/2019.] |
Filing 47 ATTORNEY APPEARANCE by Jennifer Nicole Lamirand on behalf of Purdue Frederick Company Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Jennifer Nicole Lamirand added to party Purdue Frederick Company Inc., The(pty:dft), Attorney Jennifer Nicole Lamirand added to party Purdue Pharma Inc.(pty:dft), Attorney Jennifer Nicole Lamirand added to party Purdue Pharma L.P.(pty:dft).] (Lamirand, Jennifer) [Transferred from oknd on 9/6/2019.] |
Filing 46 ATTORNEY APPEARANCE by Sanford C Coats on behalf of Purdue Frederick Company Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. (Coats, Sanford) [Transferred from oknd on 9/6/2019.] |
Filing 45 MINUTE ORDER by Court Clerk , directing Actavis LLC, Actavis Pharma Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (sc, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 44 MOTION to Remand by City of Owasso (With attachments) (Court, Todd) [Transferred from oknd on 9/6/2019.] |
Filing 43 ATTORNEY APPEARANCE by Ashley E Quinn on behalf of Actavis LLC, Actavis Pharma Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc. [Note: Attorney Ashley E Quinn added to party Actavis LLC(pty:dft), Attorney Ashley E Quinn added to party Actavis Pharma Inc.(pty:dft), Attorney Ashley E Quinn added to party Cephalon, Inc.(pty:dft), Attorney Ashley E Quinn added to party TEVA Pharmaceuticals USA, Inc.(pty:dft), Attorney Ashley E Quinn added to party Watson Laboratories, Inc.(pty:dft).] (Quinn, Ashley) [Transferred from oknd on 9/6/2019.] |
Filing 42 ATTORNEY APPEARANCE by Nicholas Vernon Merkley on behalf of Actavis LLC, Actavis Pharma Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Merkley, Nicholas) [Transferred from oknd on 9/6/2019.] |
Filing 41 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Actavis LLC, Actavis Pharma Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc.) by Actavis LLC, Actavis Pharma Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (McCampbell, Robert) [Transferred from oknd on 9/6/2019.] |
Filing 40 ATTORNEY APPEARANCE by Robert Garner McCampbell on behalf of Actavis LLC, Actavis Pharma Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (McCampbell, Robert) [Transferred from oknd on 9/6/2019.] |
Filing 39 ORDER by Judge Gregory K Frizzell ; granting #38 Motion for Extension of Time to Answer (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 38 Joint MOTION for Extension of Time to Answer (Re: State Court Petition/Complaint ) by AmerisourceBergen Corp., Cardinal Health, Inc., Harvard Drug Group, LLC, The, McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 37 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda Pharmaceuticals, Inc., Anda, Inc.) by Anda Pharmaceuticals, Inc., Anda, Inc. (Curran, Jeffrey) [Transferred from oknd on 9/6/2019.] |
Filing 36 MINUTE ORDER by Court Clerk , directing Anda Pharmaceuticals, Inc.and Anda, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 35 ORDER by Judge Gregory K Frizzell ; granting #34 Motion for Extension of Time to Answer (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 34 Unopposed MOTION for Extension of Time to Answer (Re: State Court Petition/Complaint ) by Anda Pharmaceuticals, Inc., Anda, Inc. (Curran, Jeffrey) [Transferred from oknd on 9/6/2019.] |
Filing 33 ATTORNEY APPEARANCE by Jeffrey Allen Curran on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Jeffrey Allen Curran added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Jeffrey Allen Curran added to party Anda, Inc.(pty:dft).] (Curran, Jeffrey) [Transferred from oknd on 9/6/2019.] |
Filing 32 MINUTE ORDER by Court Clerk , directing Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc., Cardinal Health, Inc. and Harvard Drug Group, LLC, The to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 31 ORDER by Judge Gregory K Frizzell There being no objection, the Unopposed Motion for Extension of Time to File Responsive Pleadings [Doc. 29] is granted ; granting #29 Motion for Extension of Time to Answer (lah, Chambers) [Transferred from oknd on 9/6/2019.] |
Filing 30 MINUTE ORDER by Court Clerk , directing McKesson Corp. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 29 Unopposed MOTION for Extension of Time to Answer or file other Responsive Pleadings (Re: State Court Petition/Complaint ) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 9/6/2019.] |
Filing 28 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Janssen Pharmaceuticals, Inc. for Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Corporate Parent Johnson & Johnson for Johnson & Johnson) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 9/6/2019.] |
Filing 27 ATTORNEY APPEARANCE by Michael W Ridgeway on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 9/6/2019.] |
Filing 26 ATTORNEY APPEARANCE by John Hunt Sparks on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Sparks, John) [Transferred from oknd on 9/6/2019.] |
Filing 25 CORPORATE DISCLOSURE STATEMENT by Cardinal Health, Inc. (Ray, Ryan) [Transferred from oknd on 9/6/2019.] |
Filing 24 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Cardinal Health, Inc., Corporate Parent Generic Drug Holdings, Inc., Corporate Parent HDG Acquisition, Inc., Corporate Parent Cardinal Health 110, LLC for Harvard Drug Group, LLC, The) by Harvard Drug Group, LLC, The (Ray, Ryan) [Transferred from oknd on 9/6/2019.] |
Filing 23 ATTORNEY APPEARANCE by Ryan A Ray on behalf of Harvard Drug Group, LLC, The (Ray, Ryan) [Transferred from oknd on 9/6/2019.] |
Filing 22 ATTORNEY APPEARANCE by Ryan A Ray on behalf of Cardinal Health, Inc. (Ray, Ryan) [Transferred from oknd on 9/6/2019.] |
Filing 21 MINUTE ORDER by Court Clerk , directing AmerisourceBergen Corp. and Quest Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 20 MINUTE ORDER by Court Clerk , directing Family Dollar Stores of Oklahoma, LLC and Quest Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) Modified on 4/1/2019 - ENTERED IN ERROR (jln, Dpty Clk). [Transferred from oknd on 9/6/2019.] |
Filing 19 ATTORNEY APPEARANCE by Kaylee Patricia Davis-Maddy on behalf of McKesson Corp. [Note: Attorney Kaylee Patricia Davis-Maddy added to party McKesson Corp.(pty:dft).] (Davis-Maddy, Kaylee) [Transferred from oknd on 9/6/2019.] |
Filing 18 STATUS REPORT on Removed Action by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 17 NOTICE Supplemental Notice of Removal by McKesson Corp. (With attachments) (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 16 CORPORATE DISCLOSURE STATEMENT by McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 15 ATTORNEY APPEARANCE by Stuart Douglas Campbell on behalf of McKesson Corp. [Note: Attorney Stuart Douglas Campbell added to party McKesson Corp.(pty:dft).] (Campbell, Stuart) [Transferred from oknd on 9/6/2019.] |
Filing 14 ORDER by Judge Gregory K Frizzell ; granting #10 Motion for Extension of Time to Answer (kjp, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 13 ATTORNEY APPEARANCE by D Michael McBride, III on behalf of AmerisourceBergen Corp. (McBride, D) [Transferred from oknd on 9/6/2019.] |
Filing 12 CORPORATE DISCLOSURE STATEMENT (identifying: Other Affiliate Walgreens Boots Alliance Holdings LLC for AmerisourceBergen Corp.) by AmerisourceBergen Corp. (Huntsman, Susan) [Transferred from oknd on 9/6/2019.] |
Filing 11 ATTORNEY APPEARANCE by Susan E Huntsman on behalf of AmerisourceBergen Corp. (Huntsman, Susan) [Transferred from oknd on 9/6/2019.] |
Filing 10 Unopposed MOTION for Extension of Time to Answer , Move, or Otherwise Respond to Petition under Rule 12 (Re: State Court Petition/Complaint ) by Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 9/6/2019.] |
Filing 9 CORPORATE DISCLOSURE STATEMENT by Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 9/6/2019.] |
Filing 8 ATTORNEY APPEARANCE by D Todd Riddles on behalf of Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 9/6/2019.] |
Filing 7 MINUTE ORDER by Court Clerk , directing Endo Health Solutions Inc., Endo Pharmaceuticals Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 6 MINUTE ORDER by Court Clerk , : Pursuant to Local Rule 81.2, the removing party(ies) shall file a Status Report on Removed Action within five (5) days of the filing of the notice of removal in the U.S. District Court. The form is available on the Court's website. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Filing 5 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Pharmaceuticals Inc.) by Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 4 CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Health Solutions Inc.) by Endo Health Solutions Inc. (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 3 ATTORNEY APPEARANCE by Raymond Edward Zschiesche on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 2 NOTICE of Removal with Jury Demand from D.C. Tulsa County, case number CJ-2019-784 (paid $400 filing fee; receipt number 1085-2033097) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
Filing 1 CIVIL COVER SHEET by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 9/6/2019.] |
PETITION/COMPLAINT with Jury Demand filed in State Court against All Defendants by City of Owasso (dlg, Dpty Clk) [Transferred from oknd on 9/6/2019.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Ohio Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.